BioAffinity Technologies Inc (NASDAQ:BIAF) currently has a daily average trading volume of 12.17M but it saw 1328860 shares traded in last market. With a market cap of 8.47M USD, the company’s current market price of $0.30 came rising about 7.22 while comparing to the previous closing price of $0.28. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.99 and as low as $0.16.
Over the week, BIAF’s stock price is moving -24.25% down while it is -20.26% when we observe its performance for the past one month. Year-to-date it is -66.70% down and over the past year, the stock is showing a downside performance of -87.38%.
The company is expected to be releasing its next quarterly report in July, for which analysts forecasted an EPS of -0.1 while estimate for next year EPS is -0.4. In next quarter, company is expected to be making quarterly sales of $1.55M as analysts are expecting the sales for current fiscal year at $6.5M and seeing the company making $7.8M in sales next year. Moreover, analysts are in estimates of $1.51M for current-quarter revenue.
Currently, BioAffinity Technologies Inc’s total number of outstanding shares is 27.96M with 24.53% of that held by the insiders while 1.80% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -456.80% and return on equity (ROE) at -290.85%. Stock’s beta reads 2.55. Stock has a price to book (P/B) ratio of 3.84 while price to sale or P/S ratio amounts to 0.96. Its return on asset (ROA) is -143.25% on average.
